RFP Financial Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-90
Closed -$48.8K 314
2024
Q2
$48.8K Hold
90
0.02% 230
2024
Q1
$46.7K Sell
90
-6
-6% -$2.98K 0.02% 214
2023
Q4
$45.3K Sell
96
-7
-7% -$3.24K 0.02% 207
2023
Q3
$44.8K Hold
103
0.02% 207
2023
Q2
$45.8K Buy
103
+5
+5% +$2.31K 0.02% 221
2023
Q1
$45.1K Buy
98
+4
+4% +$1.9K 0.05% 118
2022
Q4
$48.2K Buy
+94
New +$47.7K 0.02% 197

Other funds holding ELV

RFP Financial Group's ELV Position: Q3 2024 in Review

RFP Financial Group sold out of Elevance Health (ELV) in Q3 2024, closing a stake of 90 shares — an estimated $48.8K sold.

RFP Financial Group first reported a position in ELV in Q4 2022 and held it in 7 quarters. The position peaked at $48.8K in Q2 2024. 1,693 funds tracked by Wall St. Rank hold ELV as of Q3 2024.

  • RFP Financial Group reported no remaining Elevance Health position as of Q3 2024 after selling out during the quarter.
  • RFP Financial Group sold 90 Elevance Health shares in Q3 2024, an estimated $48.8K.
  • RFP Financial Group first reported a position in Elevance Health in Q4 2022 and held it in 7 quarters.
  • RFP Financial Group's Elevance Health position peaked at $48.8K in Q2 2024.
  • 1,693 funds tracked by Wall St. Rank held Elevance Health as of Q3 2024.

Based on RFP Financial Group's 13F filing for Q3 2024, filed 21 Oct 2024.